Renalys Pharma announces completion of primary endpoint data collection for phase III trial of sparsentan for IgA nephropathy in Japan: Tokyo, Japan Monday, October 13, 2025, 18:0 ...

P D Hinduja Hospital’s one-of-its kind Sleep Clinic to help individuals sleep better: Our Bureau, Mumbai Monday, October 13, 2025, 17:40 Hrs [IST] In response to the alarming ri ...

EMA’s veterinary medicinal products committee recommends approval of Zoetis’ Lenivia to reduce pain associated OA in dogs: Parsippany, New Jersey Monday, October 13, 2025, 16: ...

Our Bureau, Bengaluru Monday, October 13, 2025, 13:45 Hrs [IST] ...

Hikal launches state-of-the-art high potency API laboratory at its Integrated Innovation Centre, Pune: Our Bureau, Mumbai Monday, October 13, 2025, 17:50 Hrs [IST] Hikal Ltd., the ...

Research Triangle Park, North Carolina Monday, October 13, 2025, 14:00 Hrs [IST] ...

Nathealth lauds faster GST refund mechanism as a timely boost for India’s manufacturing and export ecosystem: Our Bureau, Bengaluru Monday, October 13, 2025, 16:15 Hrs [IST] Nat ...

US FDA approves Celltrion’s Eydenzelt biosimilar referencing Eylea to treat wAMD, macular edema following RVO, DME and diabetic retinopathy: Incheon, South Korea Monday, October ...

Our Bureau, Mumbai Monday, October 13, 2025, 14:30 Hrs [IST] ...

Lupin to present phase 1 data on LNP3693 at the ESMO Congress 2025: Our Bureau, Mumbai Monday, October 13, 2025, 16:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) will pre ...

NIMHANS launched National Faculty Development Programme for Psychiatrists: Our Bureau, Bengaluru Monday, October 13, 2025, 14:15 Hrs [IST] National Institute of Mental Health and ...

YD Bio business partner, EG Biomed achieves CAP accreditation, advancing US clinical testing capabilities: Taipei, Taiwan Monday, October 13, 2025, 17:00 Hrs [IST] YD Bio Limited ...